Post Tagged with: "European League Against Rheumatism"

Considering Patients’ Needs: Action and Reaction of Interleukin-6 Blockade

Considering Patients’ Needs: Action and Reaction of Interleukin-6 Blockade

Rheumatology December 1, 2017 at 8:29 AM 0 comments

This symposium took place on 14th June 2017, as a part of the European League Against Rheumatism (EULAR) 18th Annual European Congress in Madrid, Spain Chairperson: Costantino Pitzalis1 Speakers: Josef S. Smolen,2 Ernest Choy3 1. Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London SchoolRead More

Interleukin-23: The Common Link Between the Joint, the Gut, and the Skin?

Interleukin-23: The Common Link Between the Joint, the Gut, and the Skin?

Rheumatology December 1, 2017 at 8:28 AM 0 comments

This symposium took place on 16th June 2017, as a part of the European League Against Rheumatism (EULAR) 18th Annual Congress in Madrid, Spain Chairpersons: Dennis McGonagle,1 Frank Behrens2 Speakers: Dennis McGonagle,1 Frank Behrens,2 Silvio Danese3 1. University of Leeds, Leeds, UK 2. Goethe University, Frankfurt, Germany 3. Humanitas University,Read More

Time To Control Gout and Make It Crystal Clear

Time To Control Gout and Make It Crystal Clear

Rheumatology November 20, 2017 at 8:30 AM 0 comments

This symposium took place on 15th June 2017, as part of the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology 2017 in Madrid, Spain Chairpersons: Fernando Perez-Ruiz,1 Thomas Bardin,2 Alexander So3 Speakers: Till Uhlig,4 Thomas Bardin,2 Pascal Richette,2 Alexander So,3 Fernando Perez-Ruiz1 1. Basque Country University, Baracaldo, SpainRead More

Biosimilars and Switching: What is Your Perspective?

Biosimilars and Switching: What is Your Perspective?

Rheumatology August 1, 2017 at 8:29 AM 0 comments

This satellite symposium took place on 16th June 2017 as a part of the European League Against Rheumatism (EULAR) Congress in Madrid, Spain Chairperson: John Isaacs1 Speakers: John Isaacs,1 Guro Løvik Goll,2 João Gonçalves,3 Ailsa Bosworth4 1. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK 2. Department ofRead More

Switching Patients from Originator to Biosimilar Medications in Rheumatoid Arthritis: Limiting the ‘Nocebo’ Effect

Switching Patients from Originator to Biosimilar Medications in Rheumatoid Arthritis: Limiting the ‘Nocebo’ Effect

Rheumatology August 1, 2017 at 8:28 AM 0 comments

This symposium took place on 16th June as part of the European League Against Rheumatism (EULAR) Congress 2017 in Madrid, Spain Moderator: Chris Edwards1 Faculty: Merete Lund Hetland,2 Lars Erik Kristensen,2,3 Maria Cuadrado4 1. University of Southampton, Southampton, UK 2. University of Copenhagen, Copenhagen, Denmark 3. Lund University, Lund, SwedenRead More

The Patient’s Perspective on Psoriatic Arthritis: What More Can Rheumatologists Do to Optimise Disease Management?

The Patient’s Perspective on Psoriatic Arthritis: What More Can Rheumatologists Do to Optimise Disease Management?

Rheumatology August 1, 2017 at 8:27 AM 0 comments

This symposium took place on 16th June 2017 as a part of the European League Against Rheumatism (EULAR) Congress in Madrid, Spain Speakers: Juan Gomez-Reino,1 Ana-Maria Orbai,2 Laure Gossec3 1. Hospital Clinico Universitario de Santiago, La Coruña, Spain 2. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 3. Sorbonne Universités, UPMCRead More

The Evolving Landscape of Rheumatology: Biosimilarity and Extrapolation

The Evolving Landscape of Rheumatology: Biosimilarity and Extrapolation

Rheumatology August 26, 2016 at 8:30 AM 0 comments

This symposium took place on 9th June 2016, as part of the European League Against Rheumatism (EULAR) Congress 2016 in London, UK Chairperson: Peter Taylor1 Speakers: Emily Shacter,2 Craig Leonardi,3 Peter Taylor1 1. Kennedy Institute of Rheumatology, Oxford University, Oxford, UK 2. ThinkFDA, LLC, Washington DC, USA 3. Department ofRead More

Introducing New Biosimilars Into Current Treatment Algorithms

Introducing New Biosimilars Into Current Treatment Algorithms

Rheumatology July 26, 2016 at 8:30 AM 0 comments

Summary of a Biogen-sponsored symposium, held at the European League Against Rheumatism (EULAR) Congress 2016 in London, UK, on 9th June 2016 Moderator: John D. Isaacs1 Faculty: Thomas Dörner,2 Tore K. Kvien,3 Arnold Vulto4 1. Institute of Cellular Medicine, Newcastle University, Newcastle, UK 2. Department of Rheumatology and Clinical Immunology,Read More

Optimising Patient Outcomes Throughout the Rheumatoid Arthritis Patient Journey: The Exception, the Standard, and the Rule

Optimising Patient Outcomes Throughout the Rheumatoid Arthritis Patient Journey: The Exception, the Standard, and the Rule

Rheumatology July 26, 2016 at 8:29 AM 0 comments

This satellite symposium took place on 10th June 2016, as a part of the European League Against Rheumatism (EULAR) 17th annual congress in London, UK Chairperson: Peter Taylor1 Speakers: Ronald van Vollenhoven,2 Peter Taylor,1 Daniel Aletaha3 1. University of Oxford, Botnar Research Centre, Oxford, UK 2. Amsterdam Rheumatology and ImmunologyRead More

Unravelling the Mystery Between Structure and Sustained Clinical Outcomes

Unravelling the Mystery Between Structure and Sustained Clinical Outcomes

Rheumatology July 26, 2016 at 8:28 AM 0 comments

This symposium took place on 9th June 2016 as a part of the European League Against Rheumatism (EULAR) Congress 2016 in London, UK Chairperson: Edward Keystone1 Speakers: Edward Keystone,1 Leigh Revers,2 Thomas Dörner,3 1. Toronto General Research Institute, Toronto, Canada 2. University of Toronto, Toronto, Canada 3. Charité – UniversityRead More